Back to search
Cpl Life Sciences are searching for a Formulation Development Scientist to join a Global Biotechnology Research organisation based in Oxford.
Role Overview:
Design and conduct experiments to support formulation strategies for a broad range of parenteral biopharmaceuticals. Develop and perform assays to assess viscosity, injectability, and turbidity, ensuring suitability for different administration routes. Characterize physical, colloidal, and chemical stability under stress conditions and support formulation excipient screening, CMC process development, and drug compatibility with delivery systems. Collaborate with cross-functional teams to contribute to regulatory filings and development reports.
Key Responsibilities:
• Conduct and design formulation experiments for different delivery routes.
• Lead pre-formulation activities and represent formulation in CMC meetings.
• Investigate drug product compatibility with delivery devices.
• Develop and perform stability and formulation testing.
• Communicate findings to internal teams and contribute to regulatory documentation.
• Maintain accurate records and ensure compliance with health & safety policies.
• Provide technical guidance on laboratory equipment and new scientific techniques.
• Present research findings to internal and external audiences.
Required Experience & Knowledge:
• Strong background in recombinant protein or antibody formulation, analytical development, or protein characterization.
• Experience designing formulation studies using design of experiments principles.
• Expertise in sub-visible particle analysis, light scattering, chromatography, electrophoresis, and core lab techniques (ELISA, HPLC, etc).
Preferred Qualifications:
• Experience in process development and analytical characterization for biologics.
• Familiarity with biopharmaceutical stability studies and drug delivery formats.
• Strong attention to quality and ability to take on additional responsibilities.
• Experience presenting scientific findings to diverse audiences.
